Results 1 to 10 of about 208,103 (238)

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project

Haematologica, 2016
The distribution of non-Hodgkin lymphoma subtypes varies around the world, but a large systematic comparative study has never been done. In this study, we evaluated the clinical features and relative frequencies of non-Hodgkin lymphoma subtypes in five ...
Anamarija M. Perry, Jacques Diebold, Bharat N. Nathwani, Kenneth A. MacLennan, Hans K. Müller-Hermelink, Martin Bast, Eugene Boilesen, James O. Armitage, Dennis D. Weisenburger   +8 more
doaj   +2 more sources

Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents

Haematologica, 2016
Children and adolescents with pre-existing conditions such as DNA repair defects or other primary immunodeficiencies have an increased risk of non-Hodgkin lymphoma. However, large-scale data on patients with non-Hodgkin lymphoma and their entire spectrum
Andishe Attarbaschi, Elisa Carraro, Oussama Abla, Shlomit Barzilai-Birenboim, Simon Bomken, Laurence Brugieres, Eva Bubanska, Birgit Burkhardt, Alan K.S. Chiang, Monika Csoka, Alina Fedorova, Janez Jazbec, Edita Kabickova, Zdenka Krenova, Jelena Lazic, Jan Loeffen, Georg Mann, Felix Niggli, Natalia Miakova, Tomoo Osumi, Leila Ronceray, Anne Uyttebroeck, Denise Williams, Wilhelm Woessmann, Grazyna Wrobel, Marta Pillon   +25 more
doaj   +2 more sources

Composite follicular lymphoma and classic Hodgkin lymphoma [PDF]

Journal of Pathology and Translational Medicine, 2022
Composite lymphoma is very rare and a combination of Hodgkin lymphoma and non-Hodgkin lymphoma and even histiocytic tumors can occur. Because of the unfamiliarity, not only can this cause diagnostic problems, but can also affect treatment plan. We report
Han-Na Kim, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul-Won Choi, Young Hyeh Ko   +5 more
doaj   +1 more source

Head and Neck Lymphoma in an Iranian Population [PDF]

Iranian Journal of Otorhinolaryngology, 2017
Introduction: This study is aimed to assess the prevalence and characteristics of head and neck lymphoma in a defined group of an Iranian population.   Materials and Methods: In this retrospective study, 126,450 biopsy reports from two referral Pathology
Nafiseh Shamloo, Alireza Ghannadan, Mahsa Jafari, Samane Ahmadi, Hamed Mortazavi, Maryam Baharvand   +5 more
doaj   +1 more source

Epidemiology of Non-Hodgkin’s Lymphoma

Medical Science, 2021
Non-Hodgins’s lymphoma (NHL) is the most common hematological malignancy worldwide, accounting for nearly 3% of cancer diagnoses and deaths. NHL is the seventh most prevalent cancer and has the sixth highest mortality among cancers in the US.
K. Thandra, A. Barsouk, Kalyan Saginala, S. Padala, Alexander Barsouk, Prashanth Rawla   +5 more
semanticscholar   +1 more source

Role of diffusion MRI in diagnosis of mediastinal lymphoma: initial assessment and response to therapy

The Egyptian Journal of Radiology and Nuclear Medicine, 2021
Background Malignant lymphoma accounts for nearly 20% of all mediastinal neoplasms in adults and 50% in children. Hodgkin’s disease is the most common primary mediastinal lymphoma.
Youssriah Yahia Sabri, Nourhan Mohamed Ewis, Hussam Eldin Hamdy Zawam, Mostafa Ahmed Khairy   +3 more
doaj   +1 more source

Evaluation of clinical features, treatment approaches and treatment outcomes of children with non-Hodgkin lymphoma

Journal of Contemporary Medicine, 2022
Aim: To evaluate the demographic and clinical characteristics, treatment approaches and outcomes of our pediatric patients with non-Hodgkin lymphoma diagnosed and treated in our center. Material and Methods: Between 2006 and 2002, the oncologic charts of
Kübra Ertan, Serdar Uğraş, Yavuz Köksal, Buket Kara   +3 more
doaj   +1 more source

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.

New England Journal of Medicine, 2020
BACKGROUND Rituximab added to chemotherapy prolongs survival among adults with B-cell cancer. Data on its efficacy and safety in children with high-grade, mature B-cell non-Hodgkin's lymphoma are limited.
V. Minard-Colin, A. Aupérin, M. Pillon, G. Burke, D. Barkauskas, K. Wheatley, Rafael F Delgado, S. Alexander, A. Uyttebroeck, C. Bollard, J. Zsiros, M. Csóka, B. Kazanowska, A. Chiang, R. Miles, A. Wotherspoon, P. Adamson, G. Vassal, C. Patte, T. Gross   +19 more
semanticscholar   +1 more source

Determination of Hodgkin and non-Hodgkin lymphoma stage with combined positron-emission and computed tomography

Бюллетень сибирской медицины, 2011
126 patients with histological diagnosis of Hodgkin and non-Hodgkin lymphoma were examined using combined positronemission and computed tomography with radiotracer 18F-deoxyglucose. For staging Ann Arbor classification (1971) with Costwolds modification (
I. V. Boikov, G. Ye. Trufanov, V. V. Ipatov   +2 more
doaj   +1 more source

Non-Hodgkin's lymphoma: A review

Journal of Family Medicine and Primary Care, 2020
Lymphomas constitute the third most common neoplasm in head and neck region arising from the lymphoreticular system. Malignant lymphomas are divided into Hodgkin's disease and non-Hodgkin's lymphoma (NHL).
Rohit Singh, S. Shaik, B. Negi, J. Rajguru, Pankaj Patil, Dr. Anuj S. Parihar, Uma Sharma   +6 more
semanticscholar   +1 more source